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a b s t r a c t 
If improvements are to be made in tuberculosis (TB) treatment, an increased understanding of disease 
in the lung is needed. Studies have shown that bacteria in a less metabolically active state, associated 
with the presence of lipid bodies, are less susceptible to antibiotics, and recent results have highlighted 
the disparity in concentration of different compounds into lesions. Treatment success therefore depends 
critically on the responses of the individual bacteria that constitute the infection. 
We propose a hybrid, individual-based approach that analyses spatio-temporal dynamics at the cel- 
lular level, linking the behaviour of individual bacteria and host cells with the macroscopic behaviour of 
the microenvironment. The individual elements (bacteria, macrophages and T cells) are modelled using 
cellular automaton (CA) rules, and the evolution of oxygen, drugs and chemokine dynamics are incorpo- 
rated in order to study the effects of the microenvironment in the pathological lesion. We allow bacteria 
to switch states depending on oxygen concentration, which affects how they respond to treatment. This 
is the ﬁrst multiscale model of its type to consider both oxygen-driven phenotypic switching of the My- 
cobacterium tuberculosis and antibiotic treatment. Using this model, we investigate the role of bacterial 
cell state and of initial bacterial location on treatment outcome. We demonstrate that when bacteria are 
located further away from blood vessels, less favourable outcomes are more likely, i.e. longer time before 
infection is contained/cleared, treatment failure or later relapse. We also show that in cases where bac- 
teria remain at the end of simulations, the organisms tend to be slower-growing and are often located 
within granulomas, surrounded by caseous material. 
© 2018 The Authors. Published by Elsevier Ltd. 
This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
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0. Introduction 
Although tuberculosis (TB) has long been both preventable and
urable, a person dies from tuberculosis approximately every eigh-
een seconds (WHO Global Health Report 2011). Current treatment
equires at least six months of multiple antibiotics to ensure com-
lete cure and more effective drugs are urgently needed to shorten
reatment. Recent clinical trials have not resulted in a shortening of
herapy and there is a need to understand why these trials were
nsuccessful and which new regimen should be chosen for testing
n the costly long-term pivotal trial stage ( Gillespie et al., 2014 ). 
The current drug development pathway in tuberculosis is im-
erfect as standard preclinical methods may not capture the cor-
ect pharmacodynamics of the antibiotics. Using in vitro methods,∗ Corresponding author. 
E-mail address: rec9@st-andrews.ac.uk (R. Bowness). 
c  
t  
t
ttps://doi.org/10.1016/j.jtbi.2018.03.006 
022-5193/© 2018 The Authors. Published by Elsevier Ltd. This is an open access article ut is diﬃcult to accurately reproduce the natural physiological envi-
onment of Mycobacterium tuberculosis ( M. tuberculosis ) and the re-
iability of in vivo models may be limited in their ability to mimic
uman pathophysiology. 
When M. tuberculosis bacteria enter the lungs, a complex im-
une response ensues. The outcome of infection is dependent on
ow effective the host’s immune system is and on the pathogenic-
ty of the bacteria. The majority of patients will be able to con-
rol infection and contain it within a granuloma, which is a com-
ination of immune cells that surround the bacteria. The centre of
he granuloma may exhibit caseous necrosis and have a cheese-
ike appearance ( Canetti et al., 1955 ). Most commonly, granulomas
ill undergo ﬁbrosis or calciﬁcation and the infection is contained
nd becomes latent ( Canetti et al., 1955; Grosset, 1980 ). In these
ases, however, the individuals are still at risk of future relapse. If
he granulomas do not contain the disease and infection continues,
he bacteria can grow extracellularly. nder the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
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Fig. 1. Schematic of population percentages of outcomes of TB disease. Data taken from ( Ahmad, 2010 ) and references therein. 
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s  Although a minimum of six months of therapy is recom-
mended, it has long been recognised that many patients require
less and are culture negative in two months or less ( Fox, 1981 ).
Shortening treatment to four months or less results in unac-
ceptably high relapse rates ( Gillespie et al., 2014 ) and studies
( Singapore, 1981; Study, 1981 ) described in ( Fox et al., 1999 ). It has
recently been shown that, for some patients who become culture
negative in only a week, there is still a non-zero risk of relapse
( Phillips et al., 2016 ). 
Fig. 1 describes the estimates of tuberculosis containment ver-
sus progression to active disease in the general population. In
patients with established disease, the outcome is perhaps deter-
mined by the ability of antibiotics to penetrate to the granuloma
( Prideaux et al., 2015 ). In order to improve tuberculosis treatment,
it is therefore vital to ensure suﬃcient concentrations of antibiotic
reach the sites of infection ( Via et al., 2015 ). 
It is increasingly recognised that M. tuberculosis is able to enter
into a state in which it is metabolically less active. Dormant bac-
teria have reduced susceptibility to antibiotics of which cell wall
inhibitors are most affected but the action of the RNA polymerase
inhibitor rifampicin and ﬂuroquinolones acting on DNA gyrase is
also reduced ( Wayne and Hayes, 1996 ). A signiﬁcant number of
metabolic systems are down regulated in response to dormancy
inducing stresses ( Keren et al., 2004; 2011 ). This slower-growing
state, associated with the presence of lipid bodies in the mycobac-
teria can increase resistance by 15 fold ( Hammond et al., 2015 ). It
has also recently been shown that around 60% of bacteria in the
lung are lipid rich ( Baron et al., 2017 ). The reduced susceptibility
of some bacteria to antibiotics means that it is very important to
study and analyse the heterogeneity of the bacteria so more ef-
fective treatment protocols can be developed. The spatial location
of the bacteria is also vitally important as the ability of antibi-
otics to penetrate different sites of infection effectively is variable
( Prideaux et al., 2015 ). 
Multiple routes to dormancy have been reported and reviewed
in detail ( Lipworth et al., 2016 ). Oxygen concentration was one
of the ﬁrst mechanisms demonstrated in an in vitro model to
result in dormancy, and in vitro models have been developed
to explore the antibiotic susceptibility and metabolism of organ-
isms in this slower-growing state ( Wayne and Sramek, 1994 ). It
has been hypothesised by multiple authors that lesions containing
slower-growing bacteria are responsible for relapse ( Grosset, 1980;
Prideaux et al., 2015 ). 
Cellular automaton modelling (and individual-based modelling
in general) has been used to model other diseases, most notably m  umour development and progression in cancer ( Alarcón et al.,
003; Dormann and Deutsch, 2002; Gerlee and Anderson, 2007;
owathil et al., 2012; Swat et al., 2012; Zhang et al., 2009 ). Tu-
erculosis granulomas have been simulated previously through an
gent-based model called ‘GranSim’ ( Cilfone et al., 2013; Marino
t al., 2011; Pienaar et al., 2015; Segovia-Juarez et al., 2004 ), which
ims to reconstruct the immunological processes involved in the
evelopment of a granuloma. 
In ( Pienaar et al., 2016 ) the authors map metabolite and gene-
cale perturbations, ﬁnding that slowly replicating phenotypes
f M. tuberculosis preserve the bacterial population in vivo by
ontinuously adapting to dynamic granuloma microenvironments.
 Sershen et al., 2016 ) also combines a physiological model of oxy-
en dynamics, an agent-based model of cellular immune response
nd a systems-based model of M.tb metabolic dynamics. Their
tudy suggests that the dynamics of granuloma organisation me-
iates oxygen availability and illustrates the immunological contri-
ution of this structural host response to infection outcome. 
In this paper, we build on previous models such as ( Cilfone
t al., 2013; Marino et al., 2011; Pienaar et al., 2015; Segovia-Juarez
t al., 2004 ), and report the development of a hybrid-cellular au-
omaton model. Our model is the ﬁrst multiscale model to consider
oth oxygen dynamics and antibiotic treatment effects within a tu-
erculosis lesion, in order to investigate the role of bacterial cell
tate heterogeneity and bacterial position within the tuberculosis
esion on the outcome of disease. This is a unique focus for this
ype of model. 
. The hybrid multiscale mathematical model 
The model simulates the interaction between TB bacteria, T
ells and macrophages. Immune responses to the bacterial in-
ection can lead to an accumulation of dead TB bacteria and
acrophages, creating caseum. Oxygen diffuses into the system
rom blood vessels: bacteria switch from a slow-growing (lipid
ich) to a fast-growing (lipid poor) phenotype in an oxygen-
ich environment (proximate to the blood vessels). Chemokine
olecules are secreted by the macrophages, which direct the
ovement of the immune cells. We then investigate the effect that
ntibiotics have on the infection. 
Our spatial domain is a two dimensional computational grid,
here each grid point represents either a TB bacterium, a
acrophage, a T cell, caseum, the cross-section of a blood ves-
el or the extracellular matrix which goes to make up the local
icroenvironment. The spatial size of this computational grid has
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Fig. 2. Schematic describing the basic processes in the model. 
Fig. 3. Plot illustrating (a) a ﬁxed, uniform distribution of blood vessel cross sec- 
tions throughout the spatial domain used in the cellular automaton simulations and 
(b) one outcome of a random distribution of the blood vessels. 
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Deen chosen so that each automaton element is approximately the
ame size as the largest element in the system: the macrophage.
t present we allow each grid cell to be occupied by a maximum
f one element. 
Our model is made up of ﬁve main components: (1) Discrete
lements - the grid cell is occupied either by a TB bacterium, a
acrophage, a T cell, caseum or is empty. If the grid cell is oc-
upied, automaton rules control the outcome; (2) the local oxygen
oncentration, whose evolution is modelled by a partial differential
quation; (3) chemokine concentrations, modelled by a partial dif-
erential equation; (4) antibiotic concentrations, modelled by a par-
ial differential equation and (5) blood vessels from where the oxy-
en and antibiotics are supplied within the domain. A schematic
verview of the model is given in Fig. 2 . 
.1. The blood vessel network 
At the tissue scale, we consider oxygen and drug dynamics. We
ntroduce a network of blood vessels in the model, which is then
sed as a source of oxygen and antibiotic within the model. Fol-
owing Powathil et al. (2012) , we assume blood vessel cross sec-
ions are distributed throughout the two dimensional domain, with
ensity φd = N v /N 2 , where N v is the number of vessel cross sec-
ions ( Fig. 3 ). See Table 2 for values of N and N v . This is reasonable
f we assume that the blood vessels are perpendicular to the cross
ection of interest and there are no branching points through thelane of interest ( Da ¸s u et al., 2003; Patel et al., 2001 ). We ignore
ny temporal dynamics or spatial changes of these vessels. 
.2. Oxygen dynamics 
The oxygen dynamics are modelled using a partial differential
quation with the blood vessels as sources, forming a continuous
istribution within the simulation domain. If O ( x , t ) denotes the
xygen concentration at position x at time t , then its rate of change
an be expressed as 
∂O (x , t) 
∂t 
= ∇ . (D O (x ) ∇O (x , t)) + r O m (x ) − φO O (x , t) cell (x , t) , 
(1) 
here D O ( x ) is the diffusion coeﬃcient and φO is the rate of oxy-
en consumption by a bacterium or immune cell at position x at
ime t , with cell (x , t) = 1 if position x is occupied by a TB bac-
erium or immune cell at time t and zero otherwise. Oxygen con-
umption rates are different for each cell: φO b for the consump-
ion by bacteria, φO mr for resting macrophages, φO ma for active
acrophages, φO mi for infected macrophages, φO mci for chronically 
nfected macrophages and φO t for T cells (see Table 2 for these
alues). m ( x ) denotes the vessel cross section at position x , with
 (x ) = 1 for the presence of blood vessel at position x , and zero
therwise; the term r O m ( x ) therefore describes the production of
xygen at rate r O . We assume that the oxygen is supplied through
he blood vessel network, and then diffuses throughout the tis-
ue within its diffusion limit. At this time, we assume a constant
ackground oxygen level arising from airways and focus on oxy-
en diffusion from the vascular system. Since it has been observed
hat when a vessel is surrounded by caseous material, its perfusion
nd diffusion capabilities are impaired ( Datta et al., 2015; Pienaar
t al., 2016 ), we have incorporated this by considering a lower dif-
usion and supply rate in the granuloma structure as compared to
he normal vessels, i.e. 
 O = 
⎧ ⎪ ⎪ ⎨ 
⎪ ⎪ ⎩ 
D O 
D OG 
, inside a granuloma , 
D O , elsewhere in the domain, 
(2) 
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Fig. 4. Plot showing the concentration proﬁle of oxygen supplied from the blood 
vessel network for the (a) the ﬁxed, uniform distribution of blood vessels shown 
in Fig. 3 (a), and (b) the random distribution of blood vessels shown in Fig. 3 (b). 
The red coloured spheres represent the blood vessel cross sections as shown in 
Fig. 3 and the colour map shows the percentages of oxygen concentration. (For in- 
terpretation of the references to colour in this ﬁgure legend, the reader is referred 
to the web version of this article.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 
Parameter values relating to Eqs. (2) , ( 3 ), ( 5 ) and ( 6 ). 
Parameter value Reference 
D OG 2.7 ( Datta et al., 2015 ) 
r OG 4 ( Datta et al., 2015 ) 
D DrugiG 7.28 (R), 3.85 (H) ( Pienaar et al., 2016 ) 
r DrugiG 4 ( Datta et al., 2015 ) 
Table 2 
Diffusion and decay parameters for antibiotics and Chemokine 
molecules. 
Drug/Chemokine Diffusion rate (cm 2 s −1 ) Decay rate (hr −1 ) 
Rifampicin (R) 1.7 ×10 −6 0.17 
Isoniazid (H) 1.5 ×10 −5 0.35 
Pyrazinamide (Z) 1.6 ×10 −5 0.12 
Ethambutol (E) 1.3 ×10 −5 0.2 
Chemokine 10 −6 0.347 
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r O = 
⎧ ⎨ 
⎩ 
r O 
r OG 
, inside a granuloma , 
r O , elsewhere in the domain . 
(3)
The formulation of the model is then completed by prescribing no-
ﬂux boundary conditions and an initial condition ( Powathil et al.,
2012 ). Fig. 4 shows a representative proﬁle of the spatial distribu-
tion of oxygen concentration after solving the Eq. (1) with relevant
parameters as discussed in Section 2.5 . 
2.3. Antibiotic treatments 
In the present model we assume a maximum drug effect, allow-
ing us to concentrate on the focus of this paper: the comparison
of bacterial cell state and bacterial spatial location on treatment
outcome. In future papers, the administration of drugs will more
closely model the current treatment protocols. In this ﬁrst iteration
of the model, the distribution of antibiotic drug type i, Drug i ( x , t )
is governed by a similar equation to that of the oxygen distribution
(1) , given by 
∂Drug i (x , t) 
∂t 
= ∇ . (D Drugi (x ) ∇Drug i (x , t)) + r Drugi m (x ) 
− φDrugi Drug i (x , t) cell (x , t) − ηDrugi Drug i (x , t) , 
(4)
where D Drugi ( x ) is the diffusion coeﬃcient of the drug, φDrugi is
the uptake rate of the drug, with φDrugi b denoting the uptake rate
by the bacteria and φDrugi m denoting the uptake rate by the in-
fected/chronically infected macrophages. r Drugi is the drug supply
rate by the vascular network and ηDrugi is the drug decay rate. In-
side a granuloma structure, the diffusion and supply rate are lower
to account for caseum impairing blood vessels and the fact that
we know that antibiotic diffusion into granulomata is lower than
in normal lung tissue ( Kjellsson et al., 2012 ). Hence the transport
properties and delivery rate of the drug are as follows: 
D Drugi = 
⎧ ⎪ ⎨ 
⎪ ⎩ 
D Drugi 
D DrugiG 
, inside a granuloma , 
D Drugi , elsewhere in the domain, 
(5)nd 
 Drugi = 
{ r Drugi 
r DrugiG 
, inside a granuloma , 
r Drugi , elsewhere in the domain . 
(6)
The diffusion rate above is currently based on rifampicin. 
To study the eﬃcacy of the drug, we have assumed a thresh-
ld drug concentration value, below which the drug has no ef-
ect on the bacteria. If the drug reaches a bacterium or infected
acrophage when it’s concentration is above this level (which is
ifferent for fast- and slow-growing extracellular bacteria and for
ntracellular bacteria), then the bacterium will be killed and an
mpty space will be created (this will be described further in
ection 3.1 ). Parameters are discussed in Section 2.5 . 
.4. Chemokines 
Various molecules are released by macrophages and other
mmune cells, these molecules act as chemoattractants, attract-
ng other host cells to the site of infection. Although differ-
nt chemokines perform different roles at various times, for this
odel, we have chosen to represent the multiple chemokines in-
olved in the immune response as an aggregate chemokine value.
ources of chemokine are derived from infected, chronically in-
ected and activated macrophages ( Algood et al., 2003 ). The dis-
ribution of the chemokine molecules, Ch ( x , t ) is also governed in
 similar way to the oxygen and antibiotic: 
∂Ch (x , t) 
∂t 
= ∇ . (D Ch (x ) ∇Ch (x , t)) + r Ch cell (x , t) − ηCh Ch (x , t) , 
(7)
here D Ch ( x ) is the diffusion coeﬃcient of the chemokines, r Ch is
he chemokine supply rate by the macrophages at position x at
ime t , with cell (x , t) = 1 if position x is occupied by an infected,
hronically infected or activated macrophage at time t and zero
therwise. ηCh is the chemokine decay rate. 
.5. Parameter estimation 
In order to simulate the model with biologically relevant out-
omes, it is important to use accurate parameters values. Most of
he parameters are chosen from previous mathematical and exper-
mental papers (see Tables 1 –Table 3 for a summary of the param-
ter values). 
The time step was calculated by considering the fastest process
n our system, the oxygen diffusion. The oxygen dynamics are gov-
rned by a reaction diffusion equation, where the parameters are
hosen from previously published work ( Macklin et al., 2012 ). We
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Table 3 
Parameters. When there is a range for a value, it is set randomly by the model. 
Parameter Description Value Source 
N Size of grid ( N ×N ) 100 ( Segovia-Juarez et al., 2004 ) 
N v Number of blood vessels 49 ( Cilfone et al., 2013 ) 
φO b (Micromoles/cell/hr) Oxygen consumption rate of bacteria 20 . 8 × 10 −6 ( Sershen et al., 2016 ) 
φO mr (Micromoles/cell/hr) Oxygen consumption rate of Mr 1 . 15 × 10 −7 ( Sershen et al., 2016 ) 
φO ma (Micromoles/cell/hr) Oxygen consumption rate of Ma 2 . 3 × 10 −7 ( Sershen et al., 2016 ) 
φO mi (Micromoles/cell/hr) Oxygen consumption rate of Mi 3 . 45 × 10 −7 ( Sershen et al., 2016 ) 
φO mci (Micromoles/cell/hr) Oxygen consumption rate of Mci 4 . 6 × 10 −7 ( Sershen et al., 2016 ) 
φO t (Micromoles/cell/hr) Oxygen consumption rate of T cells 0 . 14375 × 10 −7 ( Sershen et al., 2016 ) 
φDrug b (Micromoles/cell/hr) Antibiotic consumption rate of extracellular bacteria 2 . 1 × 10 −11 ( Pienaar et al., 2015 ) 
φDrug mi (Micromoles/cell/hr) Antibiotic consumption rate of infected macrophages 1 . 9 × 10 −6 ( Pienaar et al., 2015 ) 
Rep f (hours) Replication rate of fast-growing bacteria 15–32 ( Shorten et al., 2013 ) 
Rep s (hours) Replication rate of slow-growing bacteria 48–96 ( Hendon-Dunn et al., 2016 ) 
O low (%) O 2 threshold for fast → slow-growing bacteria 6 Estimated - see Section 4.1 
O high (%) O 2 threshold for slow → fast-growing bacteria 65 Estimated - see Section 4.1 
Mr init Initial number of Mr in the domain 105 ( Cilfone et al., 2013 ) 
MrMa Probability of Mr → Ma (multiplied by no. of T cells in neighbourhood) 9 ( Cilfone et al., 2013 ) 
N ici Number of bacteria needed for Mi → Mci 10 ( Cilfone et al., 2013 ) 
N cib Number of bacteria needed for Mci to burst 20 ( Cilfone et al., 2013 ) 
M life (days) Lifespan of Mr, Mi and Mci 0–100 ( Van Furth et al., 1973 ) 
Ma life (days) Lifespan of Ma 10 ( Segovia-Juarez et al., 2004 ) 
t moveMr (mins) Time interval for Mr movement 20 ( Segovia-Juarez et al., 2004 ) 
t moveMa (hours) Time interval for Ma movement 7.8 ( Segovia-Juarez et al., 2004 ) 
t moveMi (hours) Time interval for Mi/Mci movement 24 ( Segovia-Juarez et al., 2004 ) 
Mr recr Probability of Mr recruitment 0.07 ( Cilfone et al., 2013 ) 
T enter Bacteria needed for T cells to enter the system 50 ( Cilfone et al., 2013 ) 
T recr Probability of T cell recruitment 0.02 ( Cilfone et al., 2013 ) 
T life (days) Lifespan of T cells 0–3 ( Sprent, 1993 ) 
T kill Probability of T cell killing Mi/Mci 0.75 ( Cilfone et al., 2013 ) 
t moveT (mins) Time interval for T cell movement 10 ( Segovia-Juarez et al., 2004 ) 
t drug (hours) Time at which drug is administered 168–2160 ( Asefa and Teshome, 2014; Osei et al., 2015 ) 
DrugKill f (%) Drug needed to kill fast-growing bacteria 2 ( Hammond et al., 2015 ) 
DrugKill s (%) Drug needed to kill slow-growing bacteria 10 ( Hammond et al., 2015 ) 
DrugKill Mi (%) Drug needed to kill intracellular bacteria 20 ( Aljayyoussi et al., 2017 ) 
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and are summarised in Table 3 . ssume a oxygen diffusion length scale of L = 100 μm and a dif-
usion constant of D O = 2 × 10 −5 cm 2 /s ( Owen et al., 2004 ). Us-
ng these along with the relation L = 
√ 
D/φ, the mean oxygen up-
ake can be approximately estimated as 0.2 s −1 . The oxygen supply
hrough the blood vessel is approximately r O = 8 . 2 × 10 −3 mols s −1 
 Matzavinos et al., 2009 ). 
Supply and diffusion rates inside a granuloma are impaired, as
escribed in Eqs. (2) , ( 3 ), ( 5 ) and ( 6 ). Parameter values are outlined
n Table 1 . 
Nondimensionalisation gives T = 0.001 hours and hence each
ime step is set to t = 0 . 001 h, with one time step corresponding
o 3.6 s. 
Because oxygen diffusion occurs on a short timescale (of the or-
er of 10 s), accurately tracking transient variations in oxygen con-
entration would require a much smaller time step. With M. tu-
erculosis replication rates of between 15 and 96 h ( Hendon-Dunn
t al., 2016; Shorten et al., 2013 ), associated timescales are much
aster and hence we assume a quasi-steady proﬁle for oxygen, with
he oxygen concentration quickly coming to equilibrium with any
hanges in the microenvironment. 
The simulations are carried out within a two dimensional do-
ain with a grid size N = 100 , which simulates an area of lung tis-
ue approximately 2 mm × 2 mm . The step size used is based on
he model proposed and developed in ( Cilfone et al., 2013; Marino
t al., 2011; Segovia-Juarez et al., 2004 ), with one grid cell corre-
ponding to the approximate diameter of the biggest discrete ele-
ent in our system, the macrophage ( Krombach et al., 1997 ). The
arameters that are used in the equations governing the dynam-
cs of antibiotics and chemokine molecules are chosen in a similar
ay. 
Oxygen is lighter in comparison to the drugs, with a molecu-
ar weight of 32 amu ( Hlatky and Alpen, 1985 ), and hence it dif-uses faster than most of the drugs and the chemokine molecules.
he chemokine molecules diffuse slower than the antibiotics, being
eavier than most drugs. One of the drugs under the current study,
ifampicin has a molecular weight of 822.9 amu (PubChem Com-
ound Database). To obtain or approximate its diffusion coeﬃcient,
ts molecular mass was compared against the molecular masses of
nown compounds, as in ( Powathil et al., 2012 ), and consequently
aken to be 1.7 ×10 −6 cm 2 s −1 . Similar analyses are done with iso-
iazid, pyrazinamide and ethambutol, with parameter values given
n Table 2 . The decay rate of these drugs are calculated using the
alf life values of the drugs obtained from the literature and are
lso outlined in Table 2 . 
The threshold drug concentrations, DrugKill f , DrugKill s and
rugKill Mi , below which the drug has no effect on the TB bac-
eria have been chosen to be the average density of total drugs
elivered through the vessels (total drug delivered/total number
f grid points) and the total drug given is kept the same for all
rugs types. Values for DrugKill f , DrugKill s and DrugKill Mi are based
n data arising from in vitro experiments and are reported in
 Aljayyoussi et al., 2017; Hammond et al., 2015 ). They are given
n Table 3 . A relative threshold is chosen here in order to compare
he effects of bacterial cell state and location of bacteria, rather
han studying any optimisation protocols for drug dosage. As more
xperimental data becomes available, these thresholds can be re-
ned. Values of 10 −6 cm 2 s −1 to 10 −7 cm 2 s −1 have been reported
s diffusion constants for chemokine molecules ( Francis and Pals-
on, 1997 ). The half-life for IL-8, an important chemokine involved
n the immune response of M. tuberculoisis , has been shown to be
–4 h ( Walz et al., 1996 ). We use a diffusion rate of 10 −6 cm 2 s −1 
nd a half-life of 2 h in our simulations. 
Other model parameters will be discussed in the next section
92 R. Bowness et al. / Journal of Theoretical Biology 446 (2018) 87–100 
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63. Cellular automaton rules 
The entire multiscale model is simulated over a prescribed time
duration, currently set to 12,0 0 0 h (50 0 days), and a vector con-
taining all grid cell positions is updated at every time step. The
oxygen dynamics, chemokine dynamics and drug dynamics are
simulated using ﬁnite difference schemes. 
3.1. Rules for the extracellular bacteria 
A minimal infectious dose of M. tuberculosis has been shown to
be of the order of 10 ( Capuano et al., 2003 ). For this reason, we be-
gin our CA simulations with one cluster of 12 bacteria on the grid;
6 fast-growing bacteria and 6 slow-growing bacteria. These initial
bacteria replicate following a set of rules and produce a cluster of
bacteria on a regular square lattice with no-ﬂux boundary condi-
tions. The fast- and slow-growing bacteria are assigned a replica-
tion rate; Rep f for the fast-growing and Rep s for the slow-growing.
When a bacterium is marked for replication, its neighbourhood of
order 3 is checked for an empty space. The neighbourhood type
alternates between a Moore neighbourhood and a Von Neumann
neighbourhood to avoid square/diamond shaped clusters, respec-
tively. If a space in the neighbourhood exists, a new bacterium is
placed randomly in one of the available grid cells. If there are no
spaces in the neighbourhood of order 3, the bacterium is marked
as ‘resting’. At each time step, the neighbourhood of these ‘resting’
bacteria are re-checked so that they can start to replicate again as
soon as space becomes available. 
As this multiscale model evolves over time, the elements move
and interact with each other according to the CA model. The bac-
teria and host cells also inﬂuence the spatial distribution of oxy-
gen since they consume oxygen for their essential metabolic ac-
tivities. As the bacteria proliferate, the oxygen demand increases
creating an imbalance between the supply and demand which will
eventually create a state where the bacteria are deprived of oxy-
gen. Bacteria can change between fast-growing and slow-growing
states, depending on the oxygen concentration, scaled from 0 to
100, at their location. Fast-growing bacteria where the oxygen con-
centration is below O low will become slow-growing, and slow-
growing bacteria can turn to fast-growing in areas where the oxy-
gen concentration is above O high (see Table 3 for these values and
Section 3.5 for more details). 
3.2. Rules for the macrophages 
There are 4 types of macrophage in our system: resting (Mr),
active (Ma), infected (Mi) and chronically infected (Mci). There are
Mr init resting macrophages randomly placed on the grid at the start
of the simulation. These resting macrophages can become active
when T cells are in their Moore neighbourhood, with probabil-
ity MrMa multiplied by the number of T cells in the neighbour-
hood. When active macrophages encounter extracellular bacteria,
they kill the bacteria. If the resting macrophages encounter bac-
teria, they become infected and can become chronically infected
when they phagocytose more than N ici bacteria. Chronically in-
fected macrophages can only contain N cib intracellular bacteria, af-
ter which they burst. Bursting macrophages distribute bacteria ran-
domly into their Moore neighbourhood of order 3 and the grid cell
where the macrophage was located becomes caseum. 
While the oxygen and antibiotics enter the system via the
blood vessel network, the chemokines are secreted by the infected,
chronically infected and activated macrophages. Macrophages
move in biased random walks, with probabilities calculated as a
function of the chemokine concentration of its Moore neighbour-
hood. Resting, infected and chronically infected macrophages are
randomly assigned a lifespan, M life days, and active macrophagesive for Ma life days. Resting macrophages move every t moveMr 
inutes, active macrophages move every t moveMa hours and in-
ected/chronically infected macrophages move every t moveMi hours.
esting macrophages are recruited from the blood vessels with a
robability of Mr recr . 
.3. Rules for the T cells 
The T cells enter the system once the extracellular bacterial
oad reaches T enter and move in a biased random walk, similar to
he macrophages. T cells are recruited from the blood vessels with
 probability T recr . They live for T life , and move every t moveT minutes.
ctivated T cells are immune effector cells that can kill chronically
nfected macrophages. If a T cell encounters an infected or chron-
cally infected macrophage, it kills the macrophage (and all intra-
ellular bacteria) with probability T kill and that grid cell becomes
aseum. T cells also activate resting macrophages when they are in
heir Moore neighbourhood, with probability MrMa multiplied by
he number of T cells in the neighbourhood. 
.4. Rules for the antibiotics 
If the immune process does not clear the infection, drugs are
dministered at t drug hours, a randomly chosen time between two
alues (see Table 3 ). This mimics the variability in time that pa-
ients seek medical attention for their disease ( Asefa and Teshome,
014; Osei et al., 2015 ). The antibiotics are administered for a
eriod of 4380 h (six months). The antibiotic kills the bacteria
hen the concentration is over DrugKill f or DrugKill s , for the fast-
nd slow-growing bacteria respectively. The antibiotics can also
ill intracellular bacteria, by killing the bacteria contained within
he infected/chronically infected macrophages if the concentra-
ion is over DrugKill Mi . These macrophages then return to resting
acrophages. 
.5. Oxygen thresholds for bacterial cell states 
In order to choose values for O low and O high , we conducted some
est simulations for 120 h, where no macrophages were present.
his allowed us to alter both the oxygen switching thresholds and
ee the effect it had on the bacteria. 90 simulations were run in to-
al, with a range of both parameters being tested. Table 4 describes
he outcome of these simulations: 
Fig. 5 shows representative examples of these test simula-
ions, where fast- and slow-growing bacteria are shown (by the
lue/cyan lines, respectively), with O high ﬁxed at 65 and O low =
 , 6 , 9 . In (a) we see the effect of having a lower threshold for
ast-growing bacteria to become slow-growing, with O low = 3 , in
b) O low = 6 and in (c), O low has a higher threshold of 9. In simu-
ation (a), the bacteria do not change state during the entire sim-
lation, Fig. 5 (a) supports this as we do not see an increase in
he cyan line that corresponds with a drop in the blue. Simulation
b) has O low = 6 and here we see some transfer from fast- to slow-
rowing during the 120 h. For simulation (c), however, the fast-
rowing bacteria transfer to slow-growing almost immediately. 
Similarly, Fig. 6 shows representative examples from varying
 high , where O low is held at 6 and O high = 55 , 65 , 75 . In simula-
ion (a), where O high = 55 , the slow-growing bacteria all change to
ast-growing very near to the beginning of the simulation. Simula-
ion (b) shows some bacteria changing state when O high = 65 , and
imulation (c) shows no transfer from fast- to slow-growing when
 high = 75 . 
These test simulations support us choosing O low = 6 and O high =
5 . 
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Table 4 
Oxygen switch. 
O low = 3 O low = 6 O low = 9 
O high = 55 All slow-growing bacteria switched to 
fast-growing in all 10 simulations by 
t = 10 h 
In 9 of the 10 simulations, all slow-growing 
bacteria changed to fast-growing by t = 10 h 
In all 10 simulations, bacteria was all the same cell 
state by t = 10 h: In 4 simulations all were 
slow-growing, in 6 simulations all were 
fast-growing 
O high = 65 No bacteria change state in any of the 
10 simulations 
In 7 of the simulations, some bacteria changed 
state: 4 from fast-growing to slow-growing and 3 
from slow-growing to fast-growing (mean time 
for ﬁrst switch was t = 21 h). In 3 of the 
simulations, no bacteria changed state. 
All fast-growing bacteria become slow-growing by 
t = 10 h in all 10 simulations 
O high = 75 No bacteria change state in any of the 
10 simulations 
No bacteria changed state in any of the 10 
simulations 
All fast-growing bacteria become slow-growing by 
t = 10 hours in all 10 simulations 
Fig. 5. Plots of the fast- (blue) and slow-growing (cyan) extracellular bacteria for the ﬁrst 120 h, with O high ﬁxed at 65 and (a) O low = 3 , (b) O low = 6 and (c) O low = 9 . (For 
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.) 
Fig. 6. Plots of the fast- (blue) and slow-growing (cyan) extracellular bacteria for the ﬁrst 120 h, with O low ﬁxed at 6 and (a) O high = 55 , (b) O high = 65 and (c) O high = 75 . (For 
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.) 
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t  . Simulation results 
In order to study the relative importance of bacterial cell state
nd initial spatial location of bacteria, we study two scenarios: one
ith a ﬁxed, uniform blood vessel distribution and initial bacterial
ocations (see four examples in Fig. 7 (a)), and another where the
essel distribution and the initial locations of the extracellular bac-
eria are determined randomly for each simulation (see examples
n Figs. 9 –11 (a)). We run a total of 120 simulations for 500 days:
0 simulations for the ‘ﬁxed’ scenario and 100 simulations for the
random’ scenario. These simulations were run on servers that have
ual Intel Xeon E5-2640 CPUs and 128GB RAM. Each simulation
ook approximately 8 hours to run. 
.1. Fixed blood vessels and initial bacterial cluster 
20 simulations were run with the same initial distribution of
 v blood vessels and with one bacterial cluster of 6 fast-growingacteria and 6 slow-growing bacteria, located in the centre of the
rid. Fig. 7 shows this initial set up. In this ‘ﬁxed’ spatial conﬁg-
ration, there was 1 blood vessel located within a 0.1 mm radius
f the bacterial cluster, situated 1 grid cell away (0.02 mm). All 20
imulations resulted in containment of the disease (which we de-
ne as fewer than 10 extracellular bacteria at the end of the 500
ays), with the macrophages and T cells preventing disease pro-
ression. In all 20 simulations no bacteria remained at the end of
he 500 days. As a granuloma develops in the simulations, caseous
ells are created at the centre. At 500 days, the simulations had
 range of 11–49 caseous grid cells with a median value of 13.5.
n only one simulation the total bacterial load exceeded T enter and
herefore T cells only appeared in one simulation. See Table 1 in
upplementary material for summary statistics for these 20 sim-
lations. Supplementary material also contains a document with
lots showing the dynamics of the T cells. 
As can be seen in Fig. 7 (i)(b), at the end of this ﬁxed simulation,
here are 10 caseous grid cells remaining, with all bacteria eradi-
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Fig. 7. Plots showing the outcome of two representative simulations, (i)–(ii), with the ﬁxed vessel distribution and initial bacterial location. (a) and (b) are plots of the spatial 
distribution of all elements: At the start of the simulation, with the initial bacterial cluster highlighted by the black circle (a) and at the end of the simulation (b). Red circles 
depict the blood vessels, black circles depict the caseum, blue circles show the fast-growing extracellular bacteria, cyan circles show the slow-growing extracellular bacteria, 
green dots depict macrophages (with darker green for the infected/chronically infected macrophages) and yellow dots depict the T cells. Plots of bacterial numbers are shown 
in (c), depicting fast-growing extracellular bacteria (dark blue), slow-growing extracellular bacteria (cyan) and intracellular bacteria (green). Note that individual ﬁgures are 
available in Supplementary material for closer inspection. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of 
this article.) 
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p  cated. In the line plot, Fig. 7 (i)(c), we see that the macrophages
effectively phagocytose the bacteria early on in the simulation and
the infected macrophages gradually die out over 2500 h (around
100 days). In the model, as a macrophage reaches the end of its
lifespan, the grid cell becomes caseum and the intracellular bacte-
ria contained within is able to burst out and grow extracellularly.
This can only happen, however, if there is space for the bacterium
to move to. If instead, as in this case, the immune response is
effective in controlling the disease with resting macrophages sur-
rounding the infection, there is no space for these intracellular bac-
teria to re-emerge as extracellular bacteria, and the bacterium dies.
Fig. 7 (ii) depicts the outcome of another example simulation
with a starting ‘ﬁxed’ distribution. Fig. 7 (ii)(b) shows the end of
this simulation with 49 caseous grid cells. If we look at the line
plot in Fig. 7 (ii)(c), we can see a more eventful simulation. The
bacteria start to grow at the beginning of the simulation and we
see a more gradual immune containment of the infection. This
is the one simulation where T cells entered the system to assist
in this containment. Because of this, the T cells are also respon-
sible for killing infected macrophages and they also activate the
macrophages, which also contribute to the killing of the infected
macrophages. In Fig. 7 (ii)(c) we also see incidences of intracellular
bacteria successfully moving out of the macrophages as they die
naturally. These can be seen as small spikes in the slow-growing
line. In many of these cases, however, these newly escaped ex-
tracellular bacteria are quickly phagocytosed again. Eventually, by
around 3700 h (around 150 days), this infection is completely erad-
icated. 
Fig. 8 shows summary plots of the 20 ﬁxed simulations, with
the mean bacterial numbers shown by the solid lines and 95% con- tdence intervals shown by the dashed lines. Fig. 8 (i) shows the
ntire 12,0 0 0 h and Fig. 8 (ii) shows only until 200 h, as this is
here most activity takes place. We can see from these plots that
here is not a great amount of variation between the 20 simula-
ions, with small differences in bacterial numbers. It is clear also
hat most of the variability takes place close to the start of the
imulations. This conﬁrms our conclusions that with a ﬁxed dis-
ribution of blood vessels and initial bacterial placement, there is
ery little difference in the outcome by the end of the simulations.
.2. Random blood vessels and initial bacterial cluster 
100 simulations were run with a random distribution of blood
essels and a random location for a bacterial cluster. The bacterial
luster consisted of 6 fast-growing bacteria and 6 slow-growing
acteria, as in the ﬁxed scenario. 90 simulations resulted in con-
ainment of the disease. Again we deﬁne containment as fewer
han 10 extracellular bacteria at the end of the 500 days. Ten sim-
lations had a number of slow-growing bacteria remaining at 500
ays, with a range 1–6. All of these remaining extracellular bac-
eria were surrounded by caseous grid cells. The other 80 simu-
ations had no extracellular bacteria remaining. 29 out of the 90
imulations had intercellular bacteria, with a range 1–41. Of these
0 ‘contained’ simulations, 32 still had a small number of either
xtracellular or intracellular bacteria remaining at the end of the
imulation (but fewer than ten extracellular bacteria) and hence
hese would be termed ‘latently infected’, where the disease is ca-
able of progressing at a later stage. Fig. 9 shows four representa-
ive examples of these 90 simulations that were contained. 
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Fig. 8. Summary plots of all 20 ﬁxed simulations. The solid line represents the mean bacterial numbers and the dashed lines show the 95% conﬁdence intervals. (i) shows 
the bacterial numbers for the entire 12,0 0 0 hours, whereas (ii) shows until time 200 hours, where most activity takes place. The fast-growing bacteria are shown by the 
blue lines in (a), the slow-growing bacteria are shown by the cyan lines in (b) and the intracellular bacteria by the green lines in (c). (For interpretation of the references to 
colour in this ﬁgure legend, the reader is referred to the web version of this article.) 
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cIn Fig. 9 (i)(b), we see an example of a simulation where the
nfection has been contained, with no extracellular bacteria and
nly 11 intracellular bacteria remaining. There is also a granu-
oma visible at 500 days, containing 102 caseous grid cells. The
ine plot shown in Fig. 9 (i) (c) describes how the immune sys-
em has contained this infection. In the 500 days of the simula-
ion, we see numerous spikes in the extracellular bacteria, as in-
ected macrophages die and the intracellular bacteria are released.
n most circumstances, this re-emergent infection is quickly con-
rolled. At roughly 90 0 0 h, however, the slow-growing bacteria be-
in to grow again. It is at this point in the simulation that T cells
re recruited, which helps to regain control of the infection. 
Fig. 9 (ii) shows another example of a contained infection, where
o treatment was needed. In this simulation, there are 6 extracel-
ular bacteria remaining at the end of the 500 days. However, as
hese are surrounded by caseous material within the granuloma
tructure, the infection is controlled and the bacteria cannot grow. 
In Fig. 9 (iii), we see a similar picture to that of shown in
ig. 9 (i). The difference here is that there was no T cell recruit-
ent needed to control the infection. By the end of the simula-
ion, we see in Fig. 9 (iii)(c) that there are 16 intracellular bacteria
emaining. 
Fig. 9 (iv) depicts a situation where the infection is controlled
ﬃciently by the host immunity. Fig. 9 (iv)(b) shows no bacteria
emaining with only 12 caseous grid cells. 
In 10 simulations, the immune response was not able to con-
ain the disease within the granuloma and active disease devel-
ped. Antibiotics were then administered at t drug hours. In seven of
hese simulations, the treatment was ‘successful’, where we deﬁne
uccess as fewer than ten extracellular bacteria at the end of 500
ays. Four of these simulations had between 1 and 8 slow-growing
xtracellular bacteria remaining at 500 days. These extracellular
acteria were all surrounded by caseous grid cells. Although these
our simulations are deemed ‘successful’, as there are a small num-
er of bacteria remaining, these cases are capable of relapsing. In
he seven successful simulations, the majority of the bacteria areilled by the antibiotics (mean value of 75.1%). Four representative
xamples of these ‘successfully treated cases’ are shown in Fig. 10 .
Fig. 10 (i) shows an example of a successfully treated simulation.
oth types of extracellular bacteria grow rapidly at the start of the
imulation, with the immune cells unable to control the infection.
s the bacteria grow, they start to consume more and more oxy-
en, reducing the availability and causing the fast-growing bacteria
o switch state. We see the clear effects of the antibiotics as they
nter the system at 535 hours, with 85.8% of the total bacteria in
he system being killed by the antibiotics at this time. No bacteria
emain at the end of this simulation. 
Fig. 10 (ii) shows another example of a successfully treated sim-
lation. Again, we see the sharp reduction of bacterial load as the
ntibiotics enter the system at 708 h, with 80.6% of the total bacte-
ia in the system being killed by the antibiotics. Shortly after this,
he host immunity controls the remaining infection. Only 1 slow-
rowing bacteria remains at the end of the simulation, surrounded
y casous grid cells. 
In Fig. 10 (iii), antibiotics were administered at 215 h, which we
ee in Fig. 10 (iii)(d) controls the infection, killing 88.9% of the total
acteria. 
Fig. 10 (iv) shows an example where, although the antibiotics
ere used and were effective, the immune response was actually
esponsible for the majority of the killing (63.5%). This is in part
ue to that fact that antibiotics were given early, at 249 h when
he bacterial burden was not particularly high. 
The remaining three simulations, were deemed ‘unsuccessful’.
n these simulations there were 16, 241 and 354 slow-growing bac-
eria remaining at 500 days. The latter two simulations are shown
n Fig. 11 . 
Fig. 11 (i) shows a case where the infection was controlled by
he host immunity for almost the entire simulation. Near the end
f the 500 days, however, the intracellular bacteria escape as the
acrophages reach the end of their lives and these newly extracel-
ular bacteria grow. This is an example of a ‘latent’ case of tuber-
ulosis where the infection reactivates at a later date. 
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Fig. 9. Plots showing the outcome of four representative simulations, (i)–(iv), of contained simulations, with a randomly placed vessel distribution and initial bacterial 
location. (a)–(b) are plots of the spatial distribution of all elements: at the start of the simulation, with the initial bacterial cluster highlighted by the black circle (a) and 
at the end of the simulation (b). Red circles depict the blood vessels, black circles depict the caseum, blue circles show the fast-growing extracellular bacteria, cyan circles 
show the slow-growing extracellular bacteria, green dots depict macrophages (with darker green for the infected/chronically infected macrophages) and yellow dots depict 
the T cells. Plots of bacterial numbers are shown in (d), depicting fast-growing extracellular bacteria (dark blue), slow-growing extracellular bacteria (cyan) and intracellular 
bacteria (green). Note that individual ﬁgures are available in Supplementary material for closer inspection. (For interpretation of the references to colour in this ﬁgure legend, 
the reader is referred to the web version of this article.) 
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g  Finally, Fig. 11 (ii) shows an example of a simulation where
treatment was received and was initially ‘successful’ but, as it can
be seen in Fig. 11 (ii)(d), at around 80 0 0 h, extracellular bacteria
begin to grow as dying macrophages release their intracellular bac-
teria. The slow-growing bacteria then continue to grow until the
end of the simulation. This is an example of a relapse. 
Fig. 12 shows summary plots of the 100 random simulations,
with the mean bacterial numbers shown by the solid lines and 95%
conﬁdence intervals shown by the dashed lines. Fig. 12 (i) shows
the entire 12,0 0 0 h and Fig. 12 (ii) shows only until 200 hours,
as this is where most activity takes place. In contrast to the ﬁxed
summary plots, we see much more variation in bacterial numbers,
especially for the slow-growing bacteria. We also note that this
variability remains for the entire 12,0 0 0 h. This further highlightshe increased variability in outcome when we investigate a random
lacement of blood vessels and bacterial cluster. 
Table 2 in supplementary material shows summary statistics for
hese 100 random simulations. Supplementary material also con-
ains a document with plots of the dynamics of the T cells. 
In the 90 ‘contained’ simulations, the median distance of ini-
ial bacterial cluster to nearest blood vessel source is 0.1 mm, with
 median value of 1 blood vessel source within a 0.1 mm radius
f the bacteria. In contrast, the other 10 simulations which were
ot contained by host immunity, the median distance to the clos-
st blood vessel source is 0.16 mm, with a median value of 0 blood
essel sources within a 0.1 mm radius of the bacteria. Comparing
he contained cases with the treated cases, a 1-tailed student t -test
ives a p value of p = 0 . 014 for proximity to closest blood vessel
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Fig. 10. Plots showing the outcome of four representative simulations, (i)–(iv), which were ‘successfully treated’, with a randomly placed vessel distribution and initial 
bacterial location. (a)–(c) are plots of the spatial distribution of all elements: at the start of the simulation, with the initial bacterial cluster highlighted by the black circle 
(a), just before the drug enters the system (b) and at the end of the simulation (c). Red circles depict the blood vessels, black circles depict the caseum, blue circles show the 
fast-growing extracellular bacteria, cyan circles show the slow-growing extracellular bacteria, green dots depict macrophages (with darker green for the infected/chronically 
infected macrophages) and yellow dots depict the T cells. Plots of bacterial numbers are shown in (d), depicting fast-growing extracellular bacteria (dark blue), slow-growing 
extracellular bacteria (cyan) and intracellular bacteria (green). Note that individual ﬁgures are available in Supplementary material for closer inspection. (For interpretation 
of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.) 
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t  nd p = 4 . 6 × 10 −5 for number of blood vessels within a 0.1 mm
adius. Hence we have shown that these groups are statistically
ifferent at the 5% level. This seems to suggest that, if the initial
acteria are located further away from the blood vessels, the less
ikely it is that the host immune response will contain the infec-
ion. 
. Discussion 
Individual-based models have already been shown to be useful
n understanding tuberculosis disease progression ( Cilfone et al.,
013; Marino et al., 2011; Pienaar et al., 2015; 2016; Segovia-Juarez
t al., 2004; Sershen et al., 2016 ). Here we have built a hybrid cel-
ular automaton model that incorporates oxygen dynamics, which
llows bacteria to change state, and includes antibiotic treatments.n addition to focusing on bacterial cell state, we also investigate
hanges in spatial location of the bacteria and their inﬂuences on
isease outcome. 
We have shown that position of bacteria in relation to the
ource of drugs alters the outcome of simulations. When analysing
he 20 simulations with a ﬁxed, uniform blood vessel distribution,
e see that there is very little difference between the simulations,
ith the host immunity containing the infection in all 20 cases.
or the random distribution of blood vessels, the location of the
acterial cluster was an important factor in determining disease
utcome. In the simulations where treatment was necessary, the
nitial bacteria were usually further away from the blood vessel
ources than those that were contained by the immune response.
he blood vessels act as sources for the immune cells and so when
he bacteria are located further away from these sources, it can
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Fig. 11. Plots showing the outcome of two representative simulations, (i)–(ii), which were ‘unsuccessfully treated’, with a randomly placed vessel distribution and initial 
bacterial location. (a)–(c) are plots of the spatial distribution of all elements: at the start of the simulation, with the initial bacterial cluster highlighted by the black circle 
(a), just before the drug enters the system (b) and at the end of the simulation (c). Red circles depict the blood vessels, black circles depict the caseum, blue circles show the 
fast-growing extracellular bacteria, cyan circles show the slow-growing extracellular bacteria, green dots depict macrophages (with darker green for the infected/chronically 
infected macrophages) and yellow dots depict the T cells. Plots of bacterial numbers are shown in (d), depicting fast-growing extracellular bacteria (dark blue), slow-growing 
extracellular bacteria (cyan) and intracellular bacteria (green). Note that individual ﬁgures are available in Supplementary material for closer inspection. (For interpretation 
of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.) 
Fig. 12. Summary plots of all 100 random simulations. The solid line represents the mean bacterial numbers and the dashed lines show the 95% conﬁdence intervals. (i) 
shows the bacterial numbers for the entire 12,0 0 0 h, whereas (ii) shows until time 200 h, where most activity takes place. The fast-growing bacteria are shown by the blue 
lines in (a), the slow-growing bacteria are shown by the cyan lines in (b) and the intracellular bacteria by the green lines in (c). (For interpretation of the references to 
colour in this ﬁgure legend, the reader is referred to the web version of this article.) 
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r  take a longer time for the immune cells to respond to and attempt
to control the infection. This extra time can give the bacteria time
to grow, making it harder for the host immunity to contain the
disease, thus in the majority of cases, antibiotics are required to
reduce the bacterial burden. We also note that in many of theimulations where the initial bacterial cluster is located near the
dge of the computational domain (examples shown in Fig. 10 ),
he host immune response tends to ﬁnd it harder to contain the
nfection. This is because the host cells cannot surround the bacte-
ia and therefore a complete granuloma cannot develop. Although
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 his is a ﬂaw in the model design, it does illustrate the importance
f effective granuloma formation. In future iterations of the model
e could consider a larger domain or look at alternative boundary
onditions to compare the effect. 
In the 100 simulations that used a random distribution of blood
essels and bacteria, we found that 90 (90%) of them were con-
ained by the host immunity but 32 of these (36%) still had some
acteria remaining, and are therefore latently infected, their dis-
ase capable of reactivating at a later date. 10 of the 100 simula-
ions (10%) required treatment and 7 of these (70%) had favourable
utcomes, with fewer than ten extracellular bacteria remaining at
he end of 500 days. The remaining three simulations had more
han ten extracellular bacteria remaining at the end of the simu-
ation. Two of these cases were treated with antibiotics, which re-
uced the bacterial load dramatically. In one case, only 16 bacteria
ere remaining and these bacteria were situated within a gran-
loma. The other case depicts a relapse, where treatment was ini-
ially successful but infection started to grow again post treatment.
he last case is an example of a latently infected individual whose
isease reactivates just before the end of the simulation. These per-
entages are comparable with those described in Fig. 1 and from
pidemiological data from the WHO on the rates of latent TB dis-
ase (World Health Organisation, 2013), with 90% of the cases re-
ulting in containment of the disease but with many capable of
ater relapse. We also show a case where an early clearance of
he bacterial load still ended up with relapse of the disease, this
s consistent with observations from the REMoxTB trial, reported
n ( Phillips et al., 2016 ). Our model simulations also show that in
he cases where bacteria remain at the end of the simulation, they
re slow-growing. This ﬁnding of persistent bacteria is also consis-
ent with the literature describing persistent TB infection in in vivo
odels ( Hu et al., 20 0 0; Manina et al., 2015 ). 
An important feature of our model is that of caseation:
hen infected macrophages burst or die, or T cells kill in-
ected macrophages, that grid cell becomes caseum. Hence, as
acrophages move chemotactically towards the clusters of bacte-
ia, a caseous granuloma starts to form and this caseum inhibits
rug diffusion. We have shown that in simulations where bacte-
ia are surrounded by caseum, they often remain at the end of the
imulation. This emphasises the importance of caseous necrosis on
he outcome of therapy. The implications of caseum have already
een demonstrated ( Grosset, 1980 ) and our simulations conﬁrm
he importance of this type of necrotic breakdown. Other hybrid
odels, such as ( Pienaar et al., 2015 ), have also included caseum,
ith non-replicating bacteria residing in the necrotic tissue and
lso call attention to this important feature in terms of treatment
utcome. With recent experimental studies such as ( Sarathy et al.,
018 ), we now have the available data to explore the drug suscep-
ibility of bacteria in caseum. 
We have also shown that bacterial cell state has an impact
n simulations, which is a characteristic that is only just start-
ng to be understood. All simulations that have extracellular bac-
eria remaining at the end of 500 days are slow-growing bacte-
ia. This is in part because any treatment received tends to kill
ff the faster-growing bacteria more quickly, perhaps leaving be-
ind a slower-growing population. These bacteria are also often
ocated inside a granuloma, where the oxygen supply and diffu-
ion rate is impaired, which favours slower-growing phenotypes.
here are relatively few publications that deﬁne the susceptibility
f slow-growing mycobacteria in relation to the standard or new
nti-tuberculosis drugs and particular emphasis should be placed
n such antibiotics that can penetrate well into lesions. 
Our preliminary simulations also highlight the importance of
patial location of the bacteria. Perhaps it is thought obvious that
patial location of the bacteria is a key factor in treatment out-
ome but previous mathematical models to date have not identi-ed this fact. Studies have focused on pharmacokinetic (PK) based
n serum and simulations of epithelial lining ﬂuid (ELF) bron-
hoalveolar lavage. Our modelling has shown that anatomical con-
iderations are important when chronic infection creates an anaer-
bic environment and ﬁbrosis around cavities. Treatment is com-
ounded further by bacterial cell state, which increases functional
IC of bacteria that can be more diﬃcult to kill due to poor pen-
tration. 
Future models could address this with enhanced understand-
ng of the effect of dormancy or phenotypic resistance. This indi-
ates the importance of work to deﬁne lesional PK ( Prideaux et al.,
015; Via et al., 2015 ). In future iterations of the model will also
nclude more anatomical and immunological complexity, for ex-
mple, airways will be added to the domain to explore its effects
nd more than one T cell will be integrated into the model. We
ould also explore the effect of ﬁbrosis and cavity formation on
utcome, building on recent concepts on lesional drug concentra-
ions ( Prideaux et al., 2015; Via et al., 2015 ). In addition, we will
odel liquefaction, which will be important to allow the release
f ‘trapped’ bacteria, thus allowing us to further investigate relapse
ases. As our understanding of M. tuberculosis cell state increases
e will also be able to reﬁne our parameter estimates of this char-
cteristic and build a better model. In future models we will also
nvestigate the effect of allowing more than one element to occupy
ach grid cell. In this model the simple drug diffusion that is mod-
lled is suﬃcient for our initial investigations. In future models we
ill integrate a PK/PD treatment model for combination therapy so
hat we can investigate the relative importance of front-line drugs
nd their role in targeting the various bacteria. 
Sputum culture conversion during treatment for tuberculosis
as a limited role in predicting the outcome of treatment for in-
ividual patients ( Phillips et al., 2016 ), so spatial models that ex-
lore TB infection and treatment in the lung are needed if we are
o increase our understanding of patient outcome. In this work we
ave shown, using an individual-based model, that a spatial model
llows us to explore many unanswered questions in TB. 
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